Rxo Capital Expenditures (CapEx) Growth & History (RXO)

Rxo's capital expenditures (capex) was $59.0M for fiscal 2025.

View full Rxo company overview

Rxo annual capital expenditures (capex) history

Rxo annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$59.0M$14.0M+31.11%
20242024-12-31$45.0M−$19.0M−29.69%
20232023-12-31$64.0M$7.0M+12.28%
20222022-12-31$57.0M$18.0M+46.15%
20212021-12-31$39.0M−$8.0M−17.02%
20202020-12-31$47.0M

Rxo capital expenditures (capex) trends

Over the last five fiscal years, Rxo's capital expenditures (capex) increased from $47.0M to $59.0M, a change of $12.0M. The latest reported quarter, Q2 2026, shows $12.0M.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rxo source filings ↗

Community posts

It’s quiet here.

No posts about RXO yet. Start the conversation.

Write the first post